-
- Jun Konishi and Kazutaka Sunami.
- Nippon Rinsho. 2015 Jan 1; 73 (1): 90-4.
AbstractThere have been major advances in the past decade in induction therapy for transplantation-eligible multiple myeloma (MM) patients. Induction therapy followed by autologous stem cell transplantation (ASCT) is the standard treatment for younger patients with MM. A high complete response rate has been achieved by three-drug induction regimens including novel agents both before and after ASCT without substantially increasing toxicity. A favorable response to therapy is a very important prognostic factor. This chapter reviews recent results on the most commonly used and tested doublet, triplet, quadruplet combinations for the treatment of newly diagnosed transplantation-eligible myeloma and provides guidance on choosing the optimal initial treatment regimen.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..